glutathione mutations in sclc patients NRF2 supports non-small cell lung cancer growth independently of CBP/p300-enhanced synthesis | EMBO Reports Frontiers | Absence of Biomarker-Driven
Frontiers Absence of Biomarker Driven Treatment Options in Small Cell Lung Cancer, and Selected Preclinical Candidates for Next Generation Combination Therapies Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small cell lung cancer patients Annals of Oncology Ferroptosis response segregates small cell lung cancer (SCLC) neuroendocrine subtypes Nature Communications Integrated methylome analysis identifies an epigenetically silenced tumor suppressor RASA4 in small cell lung cancer Communications Biology Tumor suppressor genes and KRAS G12C inhibitor resistance in non small cell lung cancer: iScience glutathione mutations in sclc patients Role of Cancer: From Mechanisms to Therapies Deep Clustering Based Metabolic Stratification of
Pay in 4 interest-free payments of $6.32 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11





